KRYS logo

Krystal Biotech, Inc. (KRYS) Cash From Operations

Annual CFO:

$123.42M+$212.22M(+238.98%)
December 31, 2024

Summary

  • As of today, KRYS annual cash from operations is $123.42 million, with the most recent change of +$212.22 million (+238.98%) on December 31, 2024.
  • During the last 3 years, KRYS annual cash from operations has risen by +$171.36 million (+357.46%).
  • KRYS annual cash from operations is now at all-time high.

Performance

KRYS Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKRYScash flow metrics

Quarterly CFO:

$52.73M+$21.76M(+70.26%)
June 30, 2025

Summary

  • As of today, KRYS quarterly cash from operations is $52.73 million, with the most recent change of +$21.76 million (+70.26%) on June 30, 2025.
  • Over the past year, KRYS quarterly cash from operations has increased by +$56.90 million (+1365.09%).
  • KRYS quarterly cash from operations is now -10.41% below its all-time high of $58.86 million, reached on September 30, 2024.

Performance

KRYS Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKRYScash flow metrics

TTM CFO:

$195.40M+$56.90M(+41.08%)
June 30, 2025

Summary

  • As of today, KRYS TTM cash from operations is $195.40 million, with the most recent change of +$56.90 million (+41.08%) on June 30, 2025.
  • Over the past year, KRYS TTM cash from operations has increased by +$212.14 million (+1267.39%).
  • KRYS TTM cash from operations is now at all-time high.

Performance

KRYS TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKRYScash flow metrics

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

KRYS Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+239.0%+1365.1%+1267.4%
3Y3 Years+357.5%+222.5%+325.4%
5Y5 Years+760.4%+1140.8%+878.3%

KRYS Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+222.7%-10.4%+254.2%at high+275.7%
5Y5-Yearat high+222.7%-10.4%+222.5%at high+275.7%
All-TimeAll-Timeat high+222.7%-10.4%+222.5%at high+275.7%

KRYS Cash From Operations History

DateAnnualQuarterlyTTM
Jun 2025
-
$52.73M(+70.3%)
$195.40M(+41.1%)
Mar 2025
-
$30.97M(-41.4%)
$138.50M(+12.2%)
Dec 2024
$123.42M(+239.0%)
$52.84M(-10.2%)
$123.42M(+94.8%)
Sep 2024
-
$58.86M(+1512.1%)
$63.34M(+478.5%)
Jun 2024
-
-$4.17M(-126.2%)
-$16.74M(+64.2%)
Mar 2024
-
$15.89M(+319.7%)
-$46.76M(+47.3%)
Dec 2023
-$88.80M(+11.7%)
-$7.23M(+65.9%)
-$88.80M(+14.5%)
Sep 2023
-
-$21.23M(+37.9%)
-$103.90M(-1.5%)
Jun 2023
-
-$34.19M(-30.7%)
-$102.36M(+8.0%)
Mar 2023
-
-$26.16M(-17.1%)
-$111.23M(-10.6%)
Dec 2022
-$100.57M(-109.8%)
-$22.33M(-13.4%)
-$100.57M(-1.4%)
Sep 2022
-
-$19.69M(+54.3%)
-$99.14M(-14.3%)
Jun 2022
-
-$43.06M(-177.9%)
-$86.71M(-61.2%)
Mar 2022
-
-$15.49M(+25.9%)
-$53.78M(-12.2%)
Dec 2021
-$47.94M(-83.8%)
-$20.90M(-188.1%)
-$47.94M(-36.7%)
Sep 2021
-
-$7.25M(+28.4%)
-$35.06M(-1.4%)
Jun 2021
-
-$10.13M(-4.9%)
-$34.57M(-17.2%)
Mar 2021
-
-$9.65M(-20.3%)
-$29.51M(-13.1%)
Dec 2020
-$26.08M
-$8.02M(-18.6%)
-$26.08M(-3.9%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$6.77M(-33.6%)
-$25.11M(-11.2%)
Jun 2020
-
-$5.07M(+18.6%)
-$22.58M(-3.9%)
Mar 2020
-
-$6.23M(+11.6%)
-$21.73M(-16.1%)
Dec 2019
-$18.69M(-97.9%)
-$7.05M(-66.1%)
-$18.71M(-23.2%)
Sep 2019
-
-$4.24M(-0.8%)
-$15.19M(-17.9%)
Jun 2019
-
-$4.21M(-30.9%)
-$12.88M(-25.2%)
Mar 2019
-
-$3.21M(+8.6%)
-$10.29M(-9.0%)
Dec 2018
-$9.45M(-142.8%)
-$3.52M(-81.3%)
-$9.45M(-17.3%)
Sep 2018
-
-$1.94M(-19.9%)
-$8.05M(-11.7%)
Jun 2018
-
-$1.62M(+31.7%)
-$7.21M(-20.2%)
Mar 2018
-
-$2.37M(-11.4%)
-$6.00M(-54.3%)
Dec 2017
-$3.89M(-196.7%)
-$2.13M(-93.7%)
-$3.89M(-48.2%)
Sep 2017
-
-$1.10M(-169.1%)
-$2.62M(-42.8%)
Jun 2017
-
-$408.00K(-58.8%)
-$1.84M(-17.2%)
Mar 2017
-
-$257.00K(+70.2%)
-$1.57M(-19.6%)
Dec 2016
-$1.31M
-$861.00K(-176.8%)
-$1.31M(-191.3%)
Sep 2016
-
-$311.00K(-123.7%)
-$450.00K(-223.7%)
Jun 2016
-
-$139.00K(>-9900.0%)
-$139.00K(>-9900.0%)
Mar 2016
-
$0.00
$0.00

FAQ

  • What is Krystal Biotech, Inc. annual cash from operations?
  • What is the all-time high annual cash from operations for Krystal Biotech, Inc.?
  • What is Krystal Biotech, Inc. annual cash from operations year-on-year change?
  • What is Krystal Biotech, Inc. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Krystal Biotech, Inc.?
  • What is Krystal Biotech, Inc. quarterly cash from operations year-on-year change?
  • What is Krystal Biotech, Inc. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Krystal Biotech, Inc.?
  • What is Krystal Biotech, Inc. TTM cash from operations year-on-year change?

What is Krystal Biotech, Inc. annual cash from operations?

The current annual cash from operations of KRYS is $123.42M

What is the all-time high annual cash from operations for Krystal Biotech, Inc.?

Krystal Biotech, Inc. all-time high annual cash from operations is $123.42M

What is Krystal Biotech, Inc. annual cash from operations year-on-year change?

Over the past year, KRYS annual cash from operations has changed by +$212.22M (+238.98%)

What is Krystal Biotech, Inc. quarterly cash from operations?

The current quarterly cash from operations of KRYS is $52.73M

What is the all-time high quarterly cash from operations for Krystal Biotech, Inc.?

Krystal Biotech, Inc. all-time high quarterly cash from operations is $58.86M

What is Krystal Biotech, Inc. quarterly cash from operations year-on-year change?

Over the past year, KRYS quarterly cash from operations has changed by +$56.90M (+1365.09%)

What is Krystal Biotech, Inc. TTM cash from operations?

The current TTM cash from operations of KRYS is $195.40M

What is the all-time high TTM cash from operations for Krystal Biotech, Inc.?

Krystal Biotech, Inc. all-time high TTM cash from operations is $195.40M

What is Krystal Biotech, Inc. TTM cash from operations year-on-year change?

Over the past year, KRYS TTM cash from operations has changed by +$212.14M (+1267.39%)
On this page